Clinical Trials Browser

Completed × Breast Neoplasms × Amplified Fragment Length Polymorphism Analysis × Clear all

NCT01281137 2021-10-06

SOLE-EST

104 enrolled 13 charts

Breast Neoplasms

NCT00968214 2020-02-21

Study of Tumor and Blood Samples From Postmenopausal Women With Primary Breast Cancer Enrolled on Clinical Trial CAN-NCIC-MA27

Breast Neoplasms

NCT00875238 2018-02-19

PACE in BC

Breast Neoplasms, Cardiotoxicity

NCT01156168 2017-05-17

Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab

Breast Neoplasms, Breast Neoplasms, Male

NCT00896623 2017-02-17

SWOG 8897-A DNA Analysis in Predicting Treatment Outcome in Women With Breast Cancer in SWOG 8897

Breast Neoplasms

NCT00516698 2016-07-13

Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer

Breast Neoplasms

NCT00899418 2013-04-04

Studying Tumor Tissue Samples to Learn More About DNA Changes and Response in Patients With Breast Cancer Treated With Bevacizumab on Clinical Trial ECOG-2100

Breast Neoplasms

NCT00900406 2012-11-06

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

BreastCNSGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Testicular Germ Cell Tumor, Breast Neoplasms, Graft vs Host Disease, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neuroblastoma, Ovarian Neoplasms, Gestational Trophoblastic Disease, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases

NCT00381901 2011-05-13

Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery

Phase 3 Completed

Breast Neoplasms